An additional clinical trial for RYANODEX for exertional heat stroke
Phase of Trial: Phase III
Latest Information Update: 10 May 2018
At a glance
- Drugs Dantrolene (Primary)
- Indications Heat stroke
- Focus Registrational; Therapeutic Use
- Sponsors Eagle Pharmaceuticals
- 10 May 2018 According to an Eagle Pharmaceuticals media release, this trial is planned for August 17-23, 2018 during the Hajj pilgrimage.
- 01 Mar 2018 New trial record
- 26 Feb 2018 According to an Eagle Pharmaceuticals media release, this trial is conducted as per the FDA suggestion in complete Response Letter regarding New Drug Application for RYANODEX for the treatment of exertional heat stroke (EHS).